Why is Astrazeneca Phar falling/rising?

As of 16-Sep, Astrazeneca Pharma India Ltd's stock price is currently at 9,026.05, reflecting an increase of 41.05, or 0.46%. The stock has shown a trend reversal, gaining after two consecutive days of decline. It is performing in line with its sector, and while it is above the 20-day, 50-day, 100-day, and 200-day moving averages, it is below the 5-day moving average. Over the past month, the stock has increased by 8.86%, significantly outperforming the Sensex, which has risen by 2.21%. The company has demonstrated high management efficiency with a return on equity of 20.34% and a low debt-to-equity ratio, contributing to its positive performance. Additionally, Astrazeneca has reported positive results for the last three consecutive quarters, with a notable growth in profit after tax and net sales.
Broader Market Context: In the short term, Astrazeneca's stock has declined by 0.66% over the past week, contrasting with the Sensex's gain of 1.58% during the same period. Despite this recent dip, the stock has shown strong performance over the longer term, with a year-to-date increase of 23.06% compared to the Sensex's 5.43%. The liquidity of the stock remains adequate for trading, although there has been a slight decrease in investor participation, as indicated by the drop in delivery volume. Overall, while the stock is experiencing some short-term volatility, its long-term performance and positive financial indicators suggest a resilient position in the market.